HLA profiles in multiple sclerosis suggest two forms of disease and the existence of protective haplotypes

Journal of the Neurological Sciences
M MadigandB Genetet

Abstract

261 multiple sclerosis (MS) patients were HLA-A and -B typed and 94 were HLA-D typed. The results were compared to those of controls typed for HLA-A; HLA-B (356) and HLA-D (113). We confirm and extend earlier findings (Oger et al. 1980b) that some phenotypes could modulate the expression of the MS susceptibility gene linked to B7-DR2: DR3 was found together with DR2 in 12/94 MS and only 3/113 controls and could be marker for an "augmentor" gene. In contrast, B35 and DR1 as well as B12 and DR7 could be markers of protector genes. We compared typing results of patients subgrouped on clinical features. 61 patients with progressive evolution showed increased A1, A1-B8, B8-DR3 and A1-B8-DR3 when compared to 200 patients with remitting evolution. When compared to controls both groups showed increased B7 but only the remitting group showed increased DR2. 71 patients with "benign MS" showed increased B7-DR2 and A3-B7-DR2. 54 patients with "severe disease" showed increased DR3 and A1-B8-DR3 when compared to controls. Both groups showed increased B7 (49.2% and 44.4% versus 25.5% for controls). 120 patients treated greater than 5 years with azathioprine were divided into "no progression" and "progression" while treated. Both groups showed...Continue Reading

References

Dec 20, 1979·The New England Journal of Medicine·A CeladaM Jeannet
Oct 1, 1979·Neurology·B R VisscherM S Park
Jan 10, 1976·British Medical Journal·W M Hutchinson, M Haire
Aug 1, 1974·Journal of the Neurological Sciences·B G ArnasonS H Wray
Jul 1, 1980·Neurology·G W Ellison, L W Myers
Nov 1, 1980·Neurology·A WilliamsD McFarlin
Dec 5, 1964·Nature·P I TERASAKI, J D MCCLELLAND
Apr 1, 2008·Journal of Evaluation in Clinical Practice·Rhiannon G EdwardsAndrew P Turner

❮ Previous
Next ❯

Citations

Aug 12, 2000·Annals of Neurology·T MastermanJ Hillert
Jan 1, 1994·Annals of Neurology·J Hillert
Jan 1, 1983·Journal of Neurology·L DejaegherH Carton
May 1, 1994·Journal of Neurology·B RunmarkerO Andersen
Mar 1, 1990·Irish Journal of Medical Science·S A HawkinsJ I Morrow
Aug 1, 1984·Journal of the Neurological Sciences·E KinnunenJ Wikström
Aug 1, 1986·Human Immunology·C GorodezkyJ Sotelo
Oct 6, 2000·Journal of the Neurological Sciences·E G CeliusA Spurkiand
Jun 27, 2002·Journal of the Neurological Sciences·G V McDonnell, S A Hawkins
Jun 24, 2005·Genes and Immunity·J R Oksenberg, L F Barcellos
Sep 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·O OlerupJ Wallin
Aug 1, 1993·Tissue Antigens·C JersildK Hyllested
Jul 20, 2004·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·I DujmovićJ Drulović
Jul 31, 2007·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·C SmestadH F Harbo
Sep 1, 1996·Acta Neurologica Scandinavica·J HillertM Söderström
Jun 1, 1987·Journal of Neurology, Neurosurgery, and Psychiatry·D A FrancisW I McDonald
Oct 1, 1992·Journal of Neurology, Neurosurgery, and Psychiatry·J HillertO Olerup
Jan 1, 1996·Journal of Neurology, Neurosurgery, and Psychiatry·G GiovannoniE J Thompson
Jan 18, 2002·Journal of Neurology, Neurosurgery, and Psychiatry·A E HensiekD A S Compston
Jul 30, 1999·Journal of the Neurological Sciences·G V McDonnellD Middleton
Feb 1, 1991·Italian Journal of Neurological Sciences·L La MantiaA Nespolo
Dec 19, 2007·Proceedings of the National Academy of Sciences of the United States of America·G C DeLucaG C Ebers
Aug 21, 2014·Cellular and Molecular Neurobiology·Alexander EmmerMalte E Kornhuber
Mar 7, 2002·Journal of Neuroimmunology·Orhun H KantarciBrian G Weinshenker
Jan 5, 2002·Journal of Neuroimmunology·Mikko LaaksonenJorma Ilonen
Dec 1, 1983·Journal of Neuroimmunology·J IlonenM Reunanen
Apr 7, 2007·Journal of the Neurological Sciences·Ana Martins SilvaBerta Martins
Jul 1, 1996·Journal of the Neurological Sciences·P BongioanniG Meucci
Jul 18, 2008·Journal of Neuroimmunology·Sreeram V RamagopalanGeorge C Ebers
Feb 1, 1984·Acta Neurologica Scandinavica·J WentzelD Bates
Apr 1, 1986·Acta Neurologica Scandinavica·M Duggan-KeenD Bates
Nov 1, 1989·Tissue Antigens·N ClericiJ Alvarez-Cermeño
Aug 1, 1994·Annals of Medicine·P J Tienari
Apr 1, 1991·Journal of Child Neurology·W A MarksJ B Bodensteiner

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.